Air from beehives comforts patients in Turkey, World News
Ceylan says people come regularly in late spring to Karaburun, in Turkey's Aegean coastal province of Izmir, mainly to supplement conventional treatment with traditional "apitherapy", a term derived from the Greek for bees.
Guests tend to stay several days in cabins in lush greenery, inhaling air from beehives for up to three hours a day, which Ceylan says helps with issues from allergies to migraines.
The government does not officially recognise the therapy though it is practiced by many other beekeepers round Turkey as well as in other countries including Germany and Russia.
Ceylan, who comes from a family of beekeepers and studied agriculture, started his bee farm in Karaburun 30 years ago. He has lobbied for years for the sector to be accepted, conducting research and presenting findings to officials.
"We are not against what we call Western medicine. After all, it is also very important too," he said, adding that his method goes hand-in-hand with conventional treatment.
"I have been doing this for fifteen years, trying to bring this into medicine." Childhood nostalgia
Ulku Ozman, 69, decided to try the therapy method after a friend suggested it when several surgeries and frequent use of medicines weakened her immune system.
In her nearly week-long visit, Ozman and others enter a cabin where ventilators connected to beehives deliver air.
Each session lasts 45 minutes, with participants moving every 15 minutes to breathe from three different beehives, each with a different smell. Guests pay around 5,000 lira (S$164) per day for the treatment plus accommodation and food.
Seated across from the beehives with ventilators on their faces, the guests take deep breaths.
Senay Ilham, 68, has breast cancer that metastasised to her spine but is in remission after receiving conventional treatment.
"This smell seems familiar. It's like it is (coming) from my childhood," she said, recalling being stung by bees while playing outside as children with beekeepers working nearby.
"(The beehive air) always brings me a breeze from these things. It relaxes me both psychologically and physically."
[[nid:715418]]
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
a day ago
- Straits Times
Americans eating (slightly) less ultra-processed food
Sign up now: Get ST's newsletters delivered to your inbox Americans on average get 55 per cent of their total calories from ultra-processed foods, data showed on Aug 7. WASHINGTON - Americans still get most of their calories from ultra-processed foods, but consumption is trending down among both adults and children, official data showed on Aug 7. The survey results from the Centres for Disease Control and Prevention (CDC) come as Health Secretary Robert F. Kennedy Jr promotes diet reform, and suggest that awareness of the risks around burgers and sodas may already have been taking hold before he came to office. Between August 2021 and August 2023, the mean percentage of total calories consumed from ultra-processed foods (UPFs) among those aged one year and older was 55 per cent. That still places the United States at or near the top of the table globally, alongside countries like the United Kingdom and Canada. Among Western nations, Italy consistently records lower UPF consumption – less than 20 per cent, according to a paper in 2024 in Public Health Nutrition that credited the Mediterranean diet. Breaking down the new US results by age, the percentage of energy consumed from UPFs was 61.9 per cent for youths aged one to 18, and 53 per cent for adults – a decline from 65.6 per cent and 56 per cent respectively during the last survey period, 2017–18. First Lady Michelle Obama spearheaded a campaign in the 2010s to encourage healthier eating and more exercise, while a landmark 2019 study in Cell Metabolism found people ate more calories when exposed to ultra-processed foods. Ultra-processed foods tend to be 'hyperpalatable, energy-dense, low in dietary fibre, and contain little or no whole foods, while having high amounts of salt, sweeteners, and unhealthy fat,' according to the CDC. They have been linked with ill health effects including higher risk of cardiovascular disease and all-cause mortality. Sandwiches, including burgers, topped the list of UPFs for both US youth and adults, followed by sweet bakery products such as donuts. Sweetened beverages were high up on both lists. Since taking office, Mr Kennedy has launched a pressure campaign on industry to remove synthetic food dyes, which appears to be paying dividends, with cereal maker Kellogg's one of the latest brands to sign on. A dozen states, meanwhile, have moved to restrict access of people with Supplemental Nutrition Assistance Programme benefits – known colloquially as food stamps – to junk food at grocery stores. AFP
Business Times
31-07-2025
- Business Times
Apac biotech sector could draw capital as investors seek diversification amid US-China tensions
[SINGAPORE] Asia-Pacific could be the new frontier for biotechnology investment, a report by consulting firm Bain & Company indicated on Thursday (Jul 31). Markets in the region are gaining ground as credible innovation hubs as global biotech strategies shift amid geopolitical tensions and deep US research funding cuts, according to the report. The report was developed jointly with the Economic Development Board, the Agency for Science, Technology and Research, JPMorgan and SG Growth Capital. 'The potential for US-based scientific talent to migrate to more favorable regions could also create an opportunity for Asia-Pacific governments and institutions to strengthen their innovation bases,' the report indicated. Favorable intellectual property regimes, regulatory agility and tax incentives – particularly in Singapore – position Apac as an attractive destination for global biotech investment, it added. Moreover, the region is winning recognition for next-generation modalities, from mRNA and cell and gene therapies to artificial intelligence-enabled drug discovery. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Fabio La Mola, partner at Bain & Company, said: 'We are looking at an exciting era for Apac's biotech sector, with the opportunity for true innovation to emerge from a geography that historically has been primarily a commercialization hub.' China leads, but geopolitical conflict pull capital away China dominates Apac's biotech investment scene, but geopolitical developments could divert capital elsewhere, said Bain & Company. The country accounted for more than 75 per cent of regional biotech venture capital and private equity flows since 2019, and industry giants like Pfizer and AstraZeneca are committing billions to research and development facilities in China, according to the report. With stunning strides over recent years, China's biotech sector is poised to challenge Western dominance on innovation. Notably, the number of Chinese novel drugs entering into development surpassed that of the European Union in 2024. However, the report noted that geopolitical tensions are reshaping biotech strategies, with biotech funding activity in China having slowed over the past few months. Amid fraught US-China relations, US pharmaceutical firms are rethinking their reliance on China and are seeking diversification to hedge against risk, Bain & Company said. 'While China continues to offer significant advantages in cost efficiency and scale, persistent geopolitical tensions and mounting policy uncertainty are diversifying capital flows into emerging hubs like Singapore and South Korea,' the company said. 'China has long been Asia-Pacific's biotech leader in terms of scale, but Singapore is emerging due to its commitment to innovation, political neutrality, intellectual property protection, and regulatory alignment,' it added. Slowing US-led innovation in early-stage R&D funding presents opportunity for Apac As tightening research budgets threaten to slow US-led innovation, particularly in early-stage academic research, Apac markets could step in to fill the gap, the report said. This comes as proposed funding cuts at the US National Institutes of Health are expected to reduce grant availability. 'As a result, Apac markets are increasingly positioned to lead in early-stage research, with big pharma likely to turn more actively to the region for sourcing innovation,' Bain & Company said. The report indicated that public funding plays an increasingly important role in supporting early-stage research, given that capital tends to flow toward later-stage, clinically-validated biotech deals, as higher investor risk aversion has led to a preference for more mature projects with clearer commercialisation pathways. This is seen in how early stage funding in Apac declined at an 11 per cent compound annual growth rate from 2019 to 2024, while late-stage biotech deal volumes grew 1.5 times. In response to the early-stage R&D funding gap, Apac governments are stepping up to seizing on the opportunity. They are launching targeted programmes providing capital and infrastructure that supports early-stage R&D projects to attract private capital investment flows to their markets. For instance, the Korea Drug Development Fund has committed US$1.6 billion to over 1,200 projects by 2030, while Japan's Bioventure Support Program is deploying US$366 million to nurture biotech startups. In Singapore, the government has allocated S$28 billion to support science and technology development, including biomedical R&D under the ongoing Research, Innovation, and Enterprise plan.
Straits Times
22-07-2025
- Straits Times
New programme by Ng Teng Fong General Hospital to tackle allergic rhinitis
Find out what's new on ST website and app. Ng Teng Fong Hospital ear, nose and throat specialist Ng Chew Lip (left) alongside his patient Ryan Lim, who has spent years managing allergic rhinitis. SINGAPORE - While in Western, often temperate, regions allergic rhinitis tends to be triggered by different allergens based on the seasons – such as pollen in the summer and mould in the winter – in tropical climates the main factor is typically dust mites. The presence of these microscopic insects, which thrive in bedding and upholstery, is why those with the condition tend to have stuffy or runny noses in the morning after waking up, said Adjunct Associate Professor Ng Chew Lip, an ear, nose and throat specialist at Ng Teng Fong General Hospital (NTFGH) . Such differences are one of the reasons for a new initiative, led by the hospital, that aims to improve the diagnosis and long-term management of allergic rhinitis here. Project ENTenna, which began in 2024, hopes to recruit up to 6,000 patients by 2026, with the aim of building a population allergy database for the condition. Data from these patients will be analysed using artificial intelligence to develop personalised treatments and ensure they regularly take their medication, so as to prevent unncessary hospital visits. The programme is supported by the National University Hospital, Tan Tock Seng Hospital (TTSH), Changi General Hospital (CGH) and A*Star. It is funded by the Ministry of Health's Health Innovation Fund and the JurongHealth Fund, a registered charity which supports NTFGH and the Jurong Community Hospital. Top stories Swipe. Select. Stay informed. Singapore Singaporeans aged 21 to 59 can claim $600 SG60 vouchers from July 22 Singapore Singaporeans continue to hold world's most powerful passport in latest ranking Singapore Woman evacuated from lift in Supreme Court building after falling glass triggers emergency halt Asia Malaysian aide's unresolved 2009 death tests govt's reform pledge despite DAP chief's apology Singapore Prosecution says judge who acquitted duo of bribing ex-LTA official had copied defence arguments Singapore Singapore not affected by haze despite smoke plumes in Sumatra: NEA Singapore Miscalculation of MOH subsidies and grants led to $7m in overpayments, $2m in shortfalls Singapore Ports and planes: The 2 Singapore firms helping to keep the world moving Also known as hay fever, allergic rhinitis occurs when a person breathes in particles that they are allergic to, such as pollen, dust mites or mould. Its symptoms are similar to those of the common cold, including uncontrollable sneezing as well as a runny nose with clear mucus. As much as 39 per cent of the population here has allergic rhinitis, said Prof Ng, a senior consultant and the principal investigator for Project ENTenna. How the condition affects Asian populations is also not well documented, he said. For example, there may be genetic differences between Western and Asian populations that influence the impact of allergic rhinitis. This means medication developed in the West may not be as effective in treating allergic rhinitis in Asians, said Prof Ng. 'What we hope for is that as Asia progresses, we develop our own specific patient treatments,' he said. A research collaboration with A*Star's Singapore Immunology Network will see molecular-level investigations undertaken to identify new therapeutic targets – referring to molecules or pathways in the body that can be affected by new treatments – as well as explore why patients experience different responses to the same treatment. The programme uses AI-powered symptom trackers and reminders to improve patients' management of their conditions. Project ENTenna can also manage other conditions such as giddiness and tinnitus, with the data-driven care model being developed possessing the potential to be expanded to other chronic conditions in the future, said the programme's co-principal investigator, Dr Tan Jian Li, a consultant with the otorhinolaryngology department at TTSH. As part of the initiative, a WhatsApp chatbot is being developed that reminds patients to take their medication on time as well as provides travel advice based on real-time updated environmental data, such as the air pollution index. 'By better understanding the varying experiences of patients living with allergic rhinitis through the chatbot, and translating information into actionable insights using the Al model, Project ENTenna can enable clinicians to move towards proactive care strategies and early interventions to enhance patient outcomes,' said CGH health services research department deputy director, Dr Oh Hong Choon. Among the 2,000 patients recruited so far is Singapore Management University student Ryan Lim, who was diagnosed with the condition about four years ago. The 21-year-old said he would often wake up feeling congested and fatigued, with his nostrils blocked for days on end on particularly bad occasions. The questionnaires and reminders he receives as part of the programme help remind him to take his medication, as well as track their effectiveness. 'I was able to better understand if the medicine wasn't really working, and say hey, let's switch to a different spray,' he said.
